These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11168896)
21. Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin. Azuma M; Kojima T; Yokoyama I; Tajiri H; Yoshikawa K; Saga S; Del Carpio CA J Pept Res; 1999 Sep; 54(3):237-41. PubMed ID: 10517161 [TBL] [Abstract][Full Text] [Related]
22. Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. Huertas Méndez NJ; Vargas Casanova Y; Gómez Chimbi AK; Hernández E; Leal Castro AL; Melo Diaz JM; Rivera Monroy ZJ; García Castañeda JE Molecules; 2017 Mar; 22(3):. PubMed ID: 28287494 [TBL] [Abstract][Full Text] [Related]
23. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. Schibli DJ; Hwang PM; Vogel HJ FEBS Lett; 1999 Mar; 446(2-3):213-7. PubMed ID: 10100843 [TBL] [Abstract][Full Text] [Related]
24. Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. Ulvatne H; Haukland HH; Samuelsen Ø; Krämer M; Vorland LH J Antimicrob Chemother; 2002 Oct; 50(4):461-7. PubMed ID: 12356789 [TBL] [Abstract][Full Text] [Related]
26. Effect of intramolecular disulfide bond of bovine lactoferricin on its molecular structure and antibacterial activity against Trueperella pyogenes separated from cow milk with mastitis. Pei J; Xiong L; Chu M; Guo X; Yan P BMC Vet Res; 2020 Oct; 16(1):401. PubMed ID: 33097042 [TBL] [Abstract][Full Text] [Related]
27. Secondary Structural Transformation of Bovine Lactoferricin Affects Its Antibacterial Activity. Pei J; Xiong L; Bao P; Chu M; Yan P; Guo X Probiotics Antimicrob Proteins; 2021 Jun; 13(3):873-884. PubMed ID: 33188636 [TBL] [Abstract][Full Text] [Related]
28. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890 [TBL] [Abstract][Full Text] [Related]
29. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. Nguyen LT; Schibli DJ; Vogel HJ J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665 [TBL] [Abstract][Full Text] [Related]
30. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins. Lejon T; Stiberg T; Strøm MB; Svendsen JS J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437 [TBL] [Abstract][Full Text] [Related]
31. Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules. Hao Y; Yang N; Wang X; Teng D; Mao R; Wang X; Li Z; Wang J Sci Rep; 2017 Mar; 7():44278. PubMed ID: 28287172 [TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor activity and selectivity of lactoferrin-derived peptides. Yang N; Stensen W; Svendsen JS; Rekdal Ø J Pept Res; 2002 Oct; 60(4):187-97. PubMed ID: 12366526 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRQWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. Huertas NJ; Monroy ZJR; Medina RF; Castañeda JEG Molecules; 2017 Jun; 22(6):. PubMed ID: 28613262 [TBL] [Abstract][Full Text] [Related]
34. Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin. Håversen L; Kondori N; Baltzer L; Hanson LA; Dolphin GT; Dunér K; Mattsby-Baltzer I Antimicrob Agents Chemother; 2010 Jan; 54(1):418-25. PubMed ID: 19917761 [TBL] [Abstract][Full Text] [Related]
35. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Chapple DS; Mason DJ; Joannou CL; Odell EW; Gant V; Evans RW Infect Immun; 1998 Jun; 66(6):2434-40. PubMed ID: 9596699 [TBL] [Abstract][Full Text] [Related]
36. The medicinal chemistry of short lactoferricin-based antibacterial peptides. Haug BE; Strøm MB; Svendsen JS Curr Med Chem; 2007; 14(1):1-18. PubMed ID: 17266565 [TBL] [Abstract][Full Text] [Related]
37. A helical region on human lactoferrin. Its role in antibacterial pathogenesis. Chapple DS; Joannou CL; Mason DJ; Shergill JK; Odell EW; Gant V; Evans RW Adv Exp Med Biol; 1998; 443():215-20. PubMed ID: 9781361 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of short arginine- and tryptophan-rich peptides. Strøm MB; Rekdal O; Svendsen JS J Pept Sci; 2002 Aug; 8(8):431-7. PubMed ID: 12212806 [TBL] [Abstract][Full Text] [Related]
39. Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212. León-Calvijo MA; Leal-Castro AL; Almanzar-Reina GA; Rosas-Pérez JE; García-Castañeda JE; Rivera-Monroy ZJ Biomed Res Int; 2015; 2015():453826. PubMed ID: 25815317 [TBL] [Abstract][Full Text] [Related]
40. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus. Vorland LH; Osbakk SA; Perstølen T; Ulvatne H; Rekdal O; Svendsen JS; Gutteberg TJ Scand J Infect Dis; 1999; 31(2):173-7. PubMed ID: 10447328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]